THE USE OF TUMOR-MARKERS IN THE MANAGEMENT OF PATIENTS WITH GYNECOLOGIC CARCINOMAS

被引:8
作者
BERCHUCK, A
BOENTE, MP
BAST, RC
机构
关键词
D O I
10.1097/00003081-199203000-00009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:45 / 54
页数:10
相关论文
共 58 条
[21]  
HALILA H, 1986, CANCER, V57, P1327, DOI 10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO
[22]  
2-Z
[23]   THE PROGNOSTIC-SIGNIFICANCE OF CA-125 HALF-LIFE IN PATIENTS WITH OVARIAN-CANCER WHO HAVE RECEIVED PRIMARY CHEMOTHERAPY AFTER SURGICAL CYTOREDUCTION [J].
HUNTER, VJ ;
DALY, L ;
HELMS, M ;
SOPER, JT ;
BERCHUCK, A ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) :1164-1167
[24]  
JACOBS I, 1988, LANCET, V1, P268
[25]   TISSUE DISTRIBUTION OF A COELOMIC-EPITHELIUM-RELATED ANTIGEN RECOGNIZED BY THE MONOCLONAL ANTIBODY-OC125 [J].
KABAWAT, SE ;
BAST, RC ;
BHAN, AK ;
WELCH, WR ;
KNAPP, RC ;
COLVIN, RB .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1983, 2 (03) :275-285
[26]   CIRCULATING LEVELS OF CSF-1 (M-CSF) A LYMPHOHEMATOPOIETIC CYTOKINE MAY BE A USEFUL MARKER OF DISEASE STATUS IN PATIENTS WITH MALIGNANT OVARIAN NEOPLASMS [J].
KACINSKI, BM ;
STANLEY, ER ;
CARTER, D ;
CHAMBERS, JT ;
CHAMBERS, SK ;
KOHORN, EI ;
SCHWARTZ, PE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (01) :159-164
[27]   THE CYTOKINE CSF-1 (M-CSF) EXPRESSED BY ENDOMETRIAL CARCINOMAS INVIVO AND INVITRO, MAY ALSO BE A CIRCULATING TUMOR-MARKER OF NEOPLASTIC DISEASE-ACTIVITY IN ENDOMETRIAL CARCINOMA PATIENTS [J].
KACINSKI, BM ;
CHAMBERS, SK ;
STANLEY, ER ;
CARTER, D ;
TSENG, P ;
SCATA, KA ;
CHANG, DHY ;
PIRRO, MH ;
NGUYEN, JT ;
ARIZA, A ;
ROHRSCHNEIDER, LR ;
ROTHWELL, VM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (03) :619-626
[28]   PROGNOSTIC-SIGNIFICANCE OF THE TUMOR-ANTIGEN TA-4 IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX [J].
KATO, H ;
MORIOKA, H ;
ARAMAKI, S ;
TAMAI, K ;
TORIGOE, T .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (03) :350-354
[29]  
KATO H, 1982, CANCER, V50, P1294, DOI 10.1002/1097-0142(19821001)50:7<1294::AID-CNCR2820500712>3.0.CO
[30]  
2-K